Acadia Pharmaceuticals

ACADIA Pharmaceuticals, Inc. is a biopharmaceutical company. The company has a portfolio of four product candidates, including pimavanserin, which is in Phase III clinical development as a treatment for Parkinson`s disease psychosis. It is also developing AGN XX/YY, a product candidate in Phase II for chronic pain; and AC-262271, a product candid....
Found on http://en.wikipedia.org/wiki/Acadia_Pharmaceuticals
No exact match found